Work

NAAG peptidase inhibition reduces locomotor activity and some stereotypes in the PCP model of schizophrenia via group II mGluR

Year: 2004

Type: article

Source: Journal of Neurochemistry

DOI: 10.1111/j.1471-4159.2004.02358.x

Authors: Rafal T. Olszewski, Noreen Bukhari, Jia Zhou, Alan P. Kozikowski, Jarda T. Wroblewski, Susan Shamimi‐Noori, Barbara Wroblewska, Tomasz Bzdega, Stefano Vicini, Franca B. Barton, Joseph H. Neale

Institutions: Georgetown University, Polish Academy of Sciences, University of Illinois Chicago

Language: English

Topic: Neuroscience and Neuropharmacology Research

Subfield: Cellular and Molecular Neuroscience

Field: Neuroscience

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Howard Hughes Medical Institute, National Institutes of Health, National Institute of Mental Health, National Institute of Neurological Disorders and Stroke

Awards: G1878308690, G3298133363, Developing NAAG Peptidase Inhibitors for Neuroprotection, NAAG Peptidase and Neuronal Function

OpenAlex ID: W1983998585

FWCI: 3.164

Cites: 50

Cited by: 137

Related to: 10